Yuxuan Che

Statistics

Publications

Citations

276

H-Index

Active since

2020

Affiliations

The University of Texas MD Anderson Cancer Center(Current)

The University of Texas Health Science Center at Houston

Yuxuan Che is an author at The University of Texas MD Anderson Cancer Center specializing in immunotherapy, lymphoma resistance, and molecular oncology.

ORCID

Publications per year

2020–2024

Publications

TIGIT is the central player in T-cell suppression associated with CAR T-cell relapse in mantle cell lymphoma

Changying Jiang, Dapeng Hao, Preetesh Jain et al. · Molecular Cancer · 2022 · 75 citations · Full text

Life Sciences, Hematology, Immunology +17

Exploiting PRMT5 as a target for combination therapy in mantle cell lymphoma characterized by frequent ATM and TP53 mutations

Yuxuan Che, Yang Liu, Yixin Yao et al. · Blood Cancer Journal · 2023 · 45 citations · Full text

Medicine, Cancer Biology, Oncology +17

Cotargeting of BTK and MALT1 overcomes resistance to BTK inhibitors in mantle cell lymphoma

Changying Jiang, Yang Liu, Junwei Lian et al. · Journal of Clinical Investigation · 2023 · 33 citations · Full text

Medicine, Oncology, Pharmacology +17

Melatonin increases the chemosensitivity of diffuse large B-cell lymphoma cells to epirubicin by inhibiting P-glycoprotein expression via the NF-κB pathway

Kai‐Li Liu, Jincheng Song, Yue Yan et al. · Translational Oncology · 2020 · 28 citations · Full text

Medicine, Oncology, Pharmacology +17

The HSP90-MYC-CDK9 network drives therapeutic resistance in mantle cell lymphoma

Fangfang Yan, Alexa A Jordan, Yuxuan Che et al. · Experimental Hematology and Oncology · 2024 · 24 citations · Full text

Medicine, Molecular Biology, Oncology +17

1–5 of 10